Study Group: Cardiologists (EU)
Council Members in this Study Group: 829
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Giuseppe Biondi-ZoccaiAssistant Professor of Cardiology
University of Turin
Giuseppe Biondi-Zoccai, MD, is an Assistant Professor of Cardiology and an Attending Physician in Interventional Cardiology at the University of Turin, Italy, since October 2006. Dr. Biondi-Zoccai has expertise in interventional cardiology, peripheral...
Goran OlivecronaConsulting Cardiologist
University of LundGoran Olivecrona, MD, PhD, is a Senior Consultant in the Department of Cardiology at Lund University Hospital, Sweden. He has expertise in interventional cardiology, in particular treatment of acute coronary syndromes and cardiogenic shock with PCI as...
- Jean-luc Vachiery
Director of the Pulmonary Vascular Diseases Clinic
CLINIQUE UNIVERSITAIRE DE BRUXELLES HOPITAL ERASME ASBLJean-Luc Vachiery, MD, FESC, is Professor of Cardiology and Director of the Pulmonary Vascular Diseases Unit at Clinique Universitaire De Bruxelles Hopital Erasme Asbl (Erasme Hospital), a European expert PAH center in Belgium. Currently, Dr. Vachiery...
- Robert Naeije
Professor and Chairman, Department of Physiology
CLINIQUE UNIVERSITAIRE DE BRUXELLES HOPITAL ERASME ASBLRobert Naeije, MD, PhD, is Professor and Chairman of the Department of Physiology and Pathophysiology and Director of the Pulmonary Hypertension Clinic at Erasme University Hospital. Dr. Naeije's main area of expertise is pulmonary circulation. His basic...
- Antonio Colombo
Director of the Cardiac Catheterization Laboratory
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABORAntonio Colombo, MD, is Director of the Cardiac Catheterization Laboratory at Columbus Hospital and San Raffaele Hospital in Milan, Italy. He is also a Visiting Professor of Medicine at Columbia University Hospital and Professor of Clinical Medicine at...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
December 15, 2008
Analysis by: Goran Olivecrona, Consulting Cardiologist,Retrospective studies should be viewed with caution. Most retrospective studies which may contain a bias in the prescribed treatment should be anlysed with matched propencity score. To confirm the results a randomized trial would essentially be needed.
-
December 5, 2008
Generic Heart Drugs as Good as Brand-Name Counterparts | www.washingtonpost.com
Generic drugs are cheaper equivalent of brand-name (aka proprietary) drugs which become available after a specific drug patent expires. There is ongoing debate whether generic drugs are as safe and as effective as their brand-name counterparts. Recent evidence from a comprehensive review published in the authoritative Journal of the American Medical Association suggests that generic drugs for heart disease are as safe and as effective as the corresponding proprietary drugs. Thus, given their lower cost, generic drugs may progressively reduce the market share of brand-name drugs, especially whenever a proprietary drug is very expensive or its market position depends only on monopoly rather than effective branding and marketing.
-
May 30, 2008
Metabolic Syndrome Not Useful in Predicting Cardiovascular Risk | www.medpagetoday.com
Metabolic syndrome is a cluster of individual characteristics that has been preliminarily associated with adverse events such as heart attack and stroke If proved an independent cause of cardiovascular disease, metabolic. syndrome could become another feasible target of pharmacologic primary prevention, eg of rimonabant, a novel drug from Sanofi-Aventis that is also under investigation for the treatment/prevention of obesity. However, recent data published in a leading journal, the Lancet, cast a shadow of doubt on independent causal role of the metabolic syndrome, suggesting that its unfavorable impact on patient outlook is largely explained by other risk factors such as increased blood pressure, increased blood lipids, and inflammation.
-
A user friendly femoral access closure device with a fast learning curve
October 15, 2007
Analysis by: Goran Olivecrona, Consulting Cardiologist,St. Jude Medical Announces Japanese Approval Of The Angio-Seal STS Plus Vascular Closure Device | www.medicalnewstoday.com
1. Angioseal is a very user friendly closure device which saves staff time spent with the patient and reduces he number of pseudoaneurysms, but it does not reduce the overall number of bleeding complications. 2. Angioiseal will probably continue to increase its market share in centers not moving to the radial access approach.
-
A new tool to improve survival rates in cardiac arrest victims?
October 15, 2007
Analysis by: Goran Olivecrona, Consulting Cardiologist,Physio-Control Announces Availability Of LUCAS™ Chest Compression System In United States | www.medicalnewstoday.com
1. LUCAS can effectively sustain circulation in spite of cardiac arrest through external mechanical chest compressions thus maintaining a sustenance of blood flow to the brain during CPR. 2. Effective external mechanical chest compression devices like LUCAS, offer a new tool to aid in the treatment of cardiac arrest victims.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
- Office Based Private Practice or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Division Head
- Physician - Director
- Professor
- Physician - Department Chair